Tilanus HW - Search Results

1

Virus-drug interactions--molecular insight into immunosuppression and HCV.

Pan Q, Tilanus HW, Metselaar HJ, Janssen HL, van der Laan LJ. Pan Q, et al. Among authors: tilanus hw. Nat Rev Gastroenterol Hepatol. 2012 Apr 17;9(6):355-62. doi: 10.1038/nrgastro.2012.67. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22508161 Free PMC article. Review.

2

Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

Henry SD, Metselaar HJ, Lonsdale RC, Kok A, Haagmans BL, Tilanus HW, van der Laan LJ. Henry SD, et al. Among authors: tilanus hw. Gastroenterology. 2006 Nov;131(5):1452-62. doi: 10.1053/j.gastro.2006.08.027. Epub 2006 Aug 14. Gastroenterology. 2006. PMID: 17101321

3

New therapeutic opportunities for hepatitis C based on small RNA.

Pan QW, Henry SD, Scholte BJ, Tilanus HW, Janssen HL, van der Laan LJ. Pan QW, et al. Among authors: tilanus hw. World J Gastroenterol. 2007 Sep 7;13(33):4431-6. doi: 10.3748/wjg.v13.i33.4431. World J Gastroenterol. 2007. PMID: 17724797 Free PMC article. Review.

4

Impact of steroids on hepatitis C virus replication in vivo and in vitro.

Henry SD, Metselaar HJ, Van Dijck J, Tilanus HW, Van Der Laan LJ. Henry SD, et al. Among authors: tilanus hw. Ann N Y Acad Sci. 2007 Sep;1110:439-47. doi: 10.1196/annals.1423.046. Ann N Y Acad Sci. 2007. PMID: 17911459

5

Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha.

Pan Q, Metselaar HJ, de Ruiter P, Kwekkeboom J, Tilanus HW, Janssen HL, van der Laan LJ. Pan Q, et al. Among authors: tilanus hw. Liver Transpl. 2010 Apr;16(4):520-6. doi: 10.1002/lt.22032. Liver Transpl. 2010. PMID: 20373462 Free article.

6

Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.

Pan Q, de Ruiter PE, Metselaar HJ, Kwekkeboom J, de Jonge J, Tilanus HW, Janssen HL, van der Laan LJ. Pan Q, et al. Among authors: tilanus hw. Hepatology. 2012 Jun;55(6):1673-83. doi: 10.1002/hep.25562. Epub 2012 Apr 18. Hepatology. 2012. PMID: 22213147

7

CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation.

van Rijen MM, Kuijf ML, Metselaar HJ, Tilanus HW, Bouma GJ, de Weger RA, Jonker M, Kwekkeboom J. van Rijen MM, et al. Among authors: tilanus hw. Transplantation. 2002 May 27;73(10):1666-72. doi: 10.1097/00007890-200205270-00024. Transplantation. 2002. PMID: 12042657

8

Pseudo-Budd-Chiari Syndrome: decompensated alcoholic liver disease mimicking hepatic venous outflow obstruction.

Janssen HL, Tan AC, Tilanus HW, Metselaar HJ, Zondervan PE, Schalm SW. Janssen HL, et al. Among authors: tilanus hw. Hepatogastroenterology. 2002 May-Jun;49(45):810-2. Hepatogastroenterology. 2002. PMID: 12063996

9

Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns.

Warlé MC, Metselaar HJ, Hop WC, Gyssens IC, Kap M, Kwekkeboom J, De Rave S, Zondervan PE, IJzermans JN, Tilanus HW, Bouma GJ. Warlé MC, et al. Among authors: tilanus hw. Transplantation. 2003 Jan 15;75(1):146-51. doi: 10.1097/00007890-200301150-00026. Transplantation. 2003. PMID: 12544887

10

Basiliximab interferes with the detection of soluble IL-2 receptor by the Immulite Immunoassay system.

Warlé MC, Kwekkeboom J, Tilanus HW, Metselaar HJ. Warlé MC, et al. Among authors: tilanus hw. J Immunol Methods. 2003 Apr 1;275(1-2):133-6. doi: 10.1016/s0022-1759(03)00016-4. J Immunol Methods. 2003. PMID: 12667677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page